The short version of regulatory status fits in a sentence. The long version — which is the one that helps — is below.
Reviewed 2026-06-26. Anything still debated is marked as such rather than presented as settled.
The peer-reviewed record is dominated by small early-phase studies, case reports and pharmacovigilance summaries rather than large randomised trials. Papers typically examine tanning response, receptor selectivity or patterns of reported adverse events. Many note that participants obtained the peptide outside a clinical setting, which limits verification of composition and administered amount. Reported events vary widely, and causality is frequently unclear because the identity and purity of self-sourced material are unknown. Open questions include whether repeated melanocortin receptor stimulation produces cumulative effects, and how often label claims match actual content.
Identification in laboratories relies on reversed-phase liquid chromatography coupled with tandem mass spectrometry, with product-ion spectra compared against a certified reference standard. High-resolution mass spectrometry supplies accurate mass confirmation, and peptide mapping after enzymatic digestion separates melanotan II from closely related analogues. Quantitation of seized material is complicated by unknown counter-ions and residual trifluoroacetate left from purification. Immunoassays raised against alpha-melanocyte-stimulating hormone can cross-react, so chromatographic confirmation is normally required. Urinary detection windows are short, and reported limits of detection differ substantially between laboratories.
Melanotan II holds no marketing authorisation from the Food and Drug Administration, the European Medicines Agency, the UK Medicines and Healthcare products Regulatory Agency or Australia's Therapeutic Goods Administration. Products sold under that name are treated as unapproved new drugs, and their sale or import is prohibited in several jurisdictions. Other countries classify the peptide as a prescription-only medicine or place it among controlled substances, so the legal position changes with the destination market. No pharmacopoeial monograph supplies an official specification, because the material is not a licensed pharmaceutical. Consequently, products offered online are not manufactured to a shared public standard.
Melanotan-2 is a synthetic cyclic heptapeptide designed as an analogue of alpha-melanocyte-stimulating hormone. Its sequence incorporates a lactam bridge that constrains the peptide into a ring, which increases resistance to enzymatic breakdown relative to the natural hormone. Researchers at the University of Arizona synthesised the compound in the late 1980s and early 1990s while studying pigmentation pathways. It has never received marketing approval from any national medicines regulator. In the scientific literature it is usually described as a laboratory research reagent rather than a therapeutic product.
The peptide acts as a non-selective agonist at melanocortin receptors, showing affinity for MC1R, MC3R, MC4R and MC5R. Activation of MC1R on melanocytes drives the conversion of tyrosine into melanin and shifts production toward the darker eumelanin form. MC4R signalling in the central nervous system is linked to appetite and energy balance, which helps explain why reduced food intake appeared in early human studies. Effects on MC4R and on vascular tone also account for the erectile responses recorded as unexpected findings in those same trials.
Melanotan-2 is frequently confused with afamelanotide, a linear analogue authorised in the European Union for erythropoietic protoporphyria. The two compounds differ in chain length, ring structure and receptor selectivity, so findings for one cannot be transferred directly to the other. Published controlled human data on melanotan-2 remain sparse, and much of what circulates online derives from small studies or unpublished reports. Questions about effect size, dose-response behaviour and long-term safety therefore remain unresolved.
| Property | Value | Notes |
|---|---|---|
| Regulatory status | Unapproved in the US, EU and Australia | Sale and import restricted; no licensed product |
| Typical test matrices | Urine, serum, seized powder | Urinary detection window is short |
| Primary identification method | LC-MS/MS against a reference standard | High-resolution mass used for confirmation |
| Data sources in the literature | Small trials, case reports, pharmacovigilance | No registrational trial dataset exists |
| Common marketing names | Melanotan 2, MT-II, MT-2 | Label content may not match declared peptide |
Published research on the compound remains limited. Much of the human data comes from small, early-stage studies rather than large controlled trials, and several questions about effects and variability between individuals remain open. Investigators have examined receptor activity, pigment pathways, and related physiological responses in laboratory and animal models. Findings from those models do not automatically translate to human outcomes. Reviews frequently note the scarcity of rigorous clinical evidence and call for better-characterized study material.
Because the substance circulates mainly through informal markets, verification is a recurring theme in technical discussion. Independent analyses have found that labeled content and actual content can diverge, and that purity varies between samples. Analytical laboratories use reversed-phase chromatography to separate components and mass spectrometry to confirm identity. Isotope-labeled internal standards improve quantification in complex matrices. Such methods describe what a sample contains but say nothing about its sterility, lawful status, or suitability for any use. Open questions remain about how consistently testing is applied across the supply chain.
Regulatory treatment of this peptide varies by country. It holds no marketing authorization as a medicine in the United States, the European Union, or most other jurisdictions. Some countries classify products containing it as prescription-only or unlicensed medicines, which restricts lawful supply. Authorities have issued public notices warning that unregulated products may contain undeclared or incorrect ingredients. The molecule also appears on prohibited lists for competitive sport. These measures address supply oversight rather than any approved therapeutic role.
Outside regulated medicine, melanotan II circulates through online vendors as a research chemical, often marketed for tanning. Products sold this way vary widely in purity, concentration, and labeling accuracy, and independent testing has documented discrepancies. Published reports describe both pigment effects and adverse reactions, including nausea, flushing, and darkening of existing moles. Long-term safety data are sparse, and no large controlled trial has established a risk profile. Questions about cumulative effects on melanocytes remain unresolved in the literature.
Melanotan II is a synthetic peptide analog modeled on alpha-melanocyte-stimulating hormone, a naturally occurring signaling peptide involved in pigmentation. Its structure is a cyclic heptapeptide containing two non-natural substitutions, norleucine at position four and D-phenylalanine at position seven. These modifications resist enzymatic breakdown and extend the molecule's activity relative to the native hormone. The compound binds melanocortin receptors and is studied mainly as a pharmacological tool rather than a therapeutic product. It has never received approval as a medicine in any major jurisdiction.
The compound was developed in the late 1980s and 1990s by academic researchers investigating photoprotection. The rationale held that stimulating melanin production might reduce ultraviolet damage to skin and lower skin cancer risk. Early work examined receptor binding, pigment response, and short-term tolerability in small studies. That program did not produce an approved drug, and formal development stalled after early-phase trials. Whether induced pigmentation confers meaningful photoprotection remains an open question.
Routine characterisation relies on reversed-phase high-performance liquid chromatography with ultraviolet detection near 214 nanometres, using a C18 column and a water-acetonitrile gradient containing trifluoroacetic acid. Electrospray ionisation mass spectrometry confirms the expected molecular mass and can reveal truncated or oxidised by-products that co-elute poorly. Sequence and stereochemistry require additional work, such as peptide mapping or amino acid analysis, because a chromatographic purity figure alone does not distinguish a diastereomer from the target peptide. Independent testing of research-grade material frequently shows measured content below the stated label, so a certificate of analysis is best read together with the method that produced it.
Melanotan-2 is handled in the laboratory as a lyophilised powder that dissolves readily in water, dimethyl sulfoxide and dimethylformamide, with limited solubility in ethanol. Stock solutions prepared in an organic solvent often precipitate when diluted into aqueous buffer, so gradual dilution with mixing is standard practice. The peptide carries a tryptophan residue and a histidine residue, both sensitive to oxidation and to alkaline conditions. Working solutions are therefore kept near neutral to slightly acidic pH, protected from light, and consumed within the same working session whenever that is practical.
== Medical uses == Cryoneuralysis has been used to relieve pain after thoracotomy, mastectomy, and knee or shoulder arthroplasty. Combined with ultrasound imaging, the procedure can be administered using a hand-held device in an office, and appears to provide an expedient, safe, and nonpharmacological option for treating various chronic pain conditions.
Cement may be created using a countercurrent kiln where the heat is passed in the cement and the exhaust combined, while the incoming air draft is passed along the two, absorbing the heat and retaining it inside the furnace, finally reaching high temperatures. Gasification: the process of creating methane and carbon monoxide from organic or fossil matter, can be done using a counter-current fixed bed ("up draft") gasifier which is built in a similar way to the Anagama kiln, and must therefore withstand more harsh conditions, but reaches better efficiency. In nuclear power plants, water leaving the plant must not contain even trace particles of Uranium. Counter Current Decantation (CCD) is used in some facilities to extract water, totally clear of Uranium.
== Musicians, composers, and lyricists == Burnet Tuthill (1909), musicologist, conductor, founder and secretary of the National Association of Schools of Music Roy Webb (1910), composer for Notorious and Abe Lincoln in Illinois Richard Hale (1914), opera and concert singer; narrator, Peter and the Wolf Oscar Hammerstein II (1916), lyricist for Show Boat, Oklahoma! and The King and I, among other Broadway musical hits Howard Dietz (1917), director of publicity for MGM and lyricist for "Dancing in the Dark" Lorenz Hart (1918), lyricist for Pal Joey and other Broadway musical hits Richard Rodgers* (1923), composer and collaborator with Lorenz Hart and Oscar Hammerstein II; wrote music for Carousel, The Sound of Music, and Victory at Sea, among many others; one of the only two people to have won an Emmy, a Grammy, an Oscar, a Tony Award, and a Pulitzer Prize Elie Siegmeister (1927), composer, music teacher, writer on music Richard Franko Goldman (1930), composer, music professor, president of the Peabody Institute 1969–1977 Milton Katims (1930), conductor, music director of the Seattle Symphony 1954–1976 Mordecai Bauman (1935), baritone Emerson Buckley (1936), conductor, The Crucible, The Ballad of Baby Doe; director of the Florida Grand Opera 1950–1973 Eddie Sauter (1936), jazz musician Elliott Schwartz (1936), composer and professor emeritus of Bowdoin College John La Touche* (1937), lyricist for Cabin in the Sky and The Golden Apple Howard Shanet (1939), conductor and composer, former head of Columbia University's music department Leonard B.
Sources: en.wikipedia.org
The film received mixed reviews from critics, but DiCaprio's performance was praised and earned him the AACTA Award for Best Actor in a Leading Role. Critic Rafer Guzman of Newsday wrote that DiCaprio was not only "tough [...] but also vulnerable, touching, funny, a faker, a human. It's a tremendous, hard-won performance." Matt Zoller Seitz of Roger Ebert's website described his performance as "the movie's greatest and simplest special effect", and "iconic—maybe his career best". The film grossed $353 million worldwide, more than three times its budget. Three films were produced by DiCaprio under Appian Way in 2013—the ensemble crime thriller Runner Runner, which The Guardian's Xan Brooks described as "a lazy, trashy film that barely goes through the motions"; the commercially failed thriller Out of the Furnace; and the black comedy-drama The Wolf of Wall Street. DiCaprio reunited with Scorsese for the fifth time in The Wolf of the Wall Street, a film based on the life of stockbroker Jordan Belfort (played by DiCaprio), who was arrested in the late 1990s for securities fraud and money laundering. DiCaprio wanted to play Belfort ever since he had read his autobiography and won a bidding war with Warner Bros. against Brad Pitt and Paramount Pictures for the rights to Belfort's memoir in 2007. He was fond of Belfort's honest and unapologetic portrayal of his actual experiences in the book, and was inspired by the 2008 financial crisis to make the film. The Wolf of Wall Street received positive reviews for Scorsese's and DiCaprio's work together.
=== Other symptoms === Breathing difficulties can occur, resulting from neuromyotonic activity of the laryngeal muscles. Laryngeal spasm possibly resulting from neuromyotonia has been described previously, and this highlights that, in patients with unexplained laryngospasm, neuromytonia should be added to the list of differential diagnoses. Studies have shown subtly decreased metabolism on positron emission tomography (PET) and single photon emission computed tomography (SPECT) in the left inferior frontal and left temporal lobes. and or basal ganglia hypermetabolism. Ancillary laboratory tests including MRI and brain biopsy have confirmed temporal lobe involvement. Cranial MRI shows increased signal in the hippocampus. Cerebral spinal fluid (CSF) shows normal protein, glucose, white blood cell, and immunoglobulin G (IgG) levels, but there are weak oligoclonal bands, which are absent in the blood serum. Marked changes in circadian serum levels of neurohormones and increased levels of peripheral neurotransmitters were also observed. The absence of morphological alterations of the brain pathology, the suggestion of diffusion of IgG into the thalamus and striatum, more marked than in the cortex (consistent with effects on the thalamolimbic system) the oligoclonal bands in the CSF and the amelioration after PE all strongly support an antibody-mediated basis for the condition. Raised CSF IgG concentrations and oligoclonal bands have been reported in patients with psychosis.
== Other uses == "Sip", a song from Joeboy Stranka Ivana Pernara, a Croatian political party Shelter-in-place, an emergency procedure Sip (kinship) Sip or Zip, one of the 18 months of the Haab', a part of the Maya calendric system SIP Grenade, self igniting phosphorus The Society of International Photographers, a not-for-profit organization founded in 1936 Soviet Interview Project, a research project conducted in the early 1980s Strangers in Paradise, an award-winning comic book State Implementation Plan, a United States state plan for complying with the federal Clean Air Act Sub-irrigated planter, a type of gardening container Sip as in SipSipStefan "Sip", a 2017 song by Chris Brown from Heartbreak on a Full Moon
== Future of Bradford Protein Assay == New modifications for an improved Bradford Protein Assay have been underway that specifically focuses on enhancing detection accuracy for collagen proteins. One notable modification involves incorporating small amounts, approximately .0035%, of sodium dodecyl sulfate (SDS). This inclusion of SDS has been shown to result in a fourfold increase in color response for three key collagen proteins—Collagen types I, III, and IV—while simultaneously decreasing the absorbance of non-collagen proteins, to bring the response curve closer between non-collagen protein and collagen protein. This simple modification in the preparation of the reagent resulted in Bradford Assays to produce similar response curves for both collagen and non-collagen proteins, expanding the use of Bradford Assays in samples containing high collagen proteins.
Sources: en.wikipedia.org
== Side effects == While botulinum toxin is generally considered safe in a clinical setting, serious side effects from its use can occur. Most commonly, botulinum toxin can be injected into the wrong muscle group or with time spread from the injection site, causing temporary paralysis of unintended muscles. In at least three cases temporary diplopia was reported due to subcutaneous injections for cosmetic purposes. Side effects from cosmetic use generally result from unintended paralysis of facial muscles. These include partial facial paralysis, muscle weakness, and trouble swallowing. Side effects are not limited to direct paralysis, however, and can also include headaches, flu-like symptoms, and allergic reactions. Just as cosmetic treatments only last a number of months, paralysis side effects can have the same durations. At least in some cases, these effects are reported to dissipate in the weeks after treatment. Bruising at the site of injection is not a side effect of the toxin, but rather of the mode of administration, and is reported as preventable if the clinician applies pressure to the injection site; when it occurs, it is reported in specific cases to last 7–11 days. When injecting the masseter muscle of the jaw, loss of muscle function can result in a loss or reduction of power to chew solid foods. With continued high doses, the muscles can atrophy or lose strength; research has shown that those muscles rebuild after a break from Botox.
Junalis was also responsible for killing another taxi driver Seing Koo Wan. 1995: Jamaludin Ibrahim, a Singaporean repairman who killed his two neighbours after robbing them. He was hanged on 28 July 1995. 1996: Panya Marmontree, Prawit Yaowabutr, Manit Wangjaisuk, Panya Amphawa, and Prasong Bunsom, all citizens of Thailand, hanged on 15 March 1996 for the murders of three men during an island-wide spree of construction site robberies between November 1992 and September 1993. 1996: John Martin Scripps, a British serial killer hanged on 19 April 1996 for murdering three tourists. 1996: Zainal Abidin Abdul Malik, a 29-year-old Singaporean who used an axe to murder 47-year-old police officer Boo Tiang Huat. He was convicted for murder and hanged on 30 August 1996. 1998: Jimmy Chua Hwa Soon, a former army sergeant who killed his sister-in-law and slashed his nephew. He was sentenced to death for murder in April 1997 and lost his appeal in February 1999: Jonaris Badlishah, a Malaysian and nephew of the Sultan of Kedah who was sentenced to death for the 1998 murder of Sally Poh Bee Eng and theft of her Rolex watch. He lost his appeal in February 1999, and afterwards, he was hanged. 1999: S. Nagarajan Kuppusamy, a Singaporean lorry driver found guilty of murdering a prison warden and put to death on 23 July 1999. 2002: Three men - Rosli bin Ahmat, Wan Kamil bin Mohamed Shafian, and Ibrahim bin Mohamed - were executed on 25 October 2002 for the August 2000 murders of Koh Ngiap Yong and Jahabar Sathick at Chestnut Avenue and Jalan Kukoh respectively.
Surgeons who perform serial sectioning through the block of tissue (usually 100 micrometres apart) are assured of the contiguous nature of his tumor and the distance of the tumor from the surgical margin, and are familiarized with the nature of the tumor. Serial sectioning also makes it easier to work with three-dimensional tumor with margins that are difficult to compress. Compression artifact, freezing artifact, cautery artifact, tissue folds, crush artifact from forceps, relaxing incision artifact, cartilage dropping out, fat compression, poor staining, dropping of tumor, etc. These can be introduced as the tumor is "flattened". Stain can run from the surgical edge, and stain the surgical margin – giving a false impression that the entire surgical margin is clear, when it is not. While some surgeons unfamiliar with the "whole piece" or "PacMan" methods of processing might suggest that multiple piece sectioning is better than one, in fact the more tissue sections are cut, the more artifacts in staining and tissue malformation will be introduced. It is imperative that the surgeon be fully familiar with tissue handling and processing; and not simply rely on a trained technologist to perform their sectioning. Hard-to-see tumor in heavy inflammatory infiltrate. This can occur with squamous cell carcinoma, especially when complicated with local infection, or intrinsic lymphoproliferative disorders (chronic lymphocytic leukemia).
Pressed and dried: Vascular plant (flowering plants, conifers, ferns) specimens are pressed and dried plants that are mounted on herbarium sheets. Various techniques are used to attach the plants with the most common method of using archival adhesive with heavier portions of the plant supported additionally by linen thread or narrow strips of gum-backed linen tape or polyester film. Specimens are best pressed with moderate pressure, permitting as much air circulation as possible. This is commonly achieved by strapping sheets in a press made of heavy cardboard or plywood. If there are loose seeds or fruits, these are placed in a small fragment packet, which also is glued to the sheet. A label with collection information is glued on the bottom right corner. Dried: Small bryophytes (mosses, hepatics or liverworts, and hornworts) are dried and placed loosely in folded packets. The label is glued on the front of the packet and the packets are filed loosely in boxes, glued to sheets of mounting paper, or placed loosely in folders. Stored in fluid: Preserved material can be kept in a glass jar filled with preservative fluid. By storing this way, the botanical specimens are maintained in a usable condition by inhibiting enzymatic and microbial attack. This method can be used where drying, pressing and mounting on a herbarium sheet is unsuitable. This method allows for a better three-dimensional arrangement of flower parts or fruits for storage.
Ultraviolet-fluorescence observations in some bloodstain regions have been interpreted as indicating that blood-related fluids may have reduced or prevented body-image formation in those areas, implying that the blood predated the image-forming process. This is further supported by microchemical tests in which, after protein material from blood-area fibers was removed, the linen fibers appeared similar to non-image fibers rather than to the body-image fibers.
Sources: en.wikipedia.org
Regulatory treatment varies by country. In the United States, the European Union and Australia it is an unapproved drug and its sale is restricted, while some other jurisdictions list it as prescription-only or controlled. The applicable rules depend on the country of import.
Reversed-phase LC-MS/MS is the usual approach for both identification and quantitation. High-resolution mass spectrometry and peptide mapping serve as confirmatory methods. Immunoassays are rarely used alone because of cross-reactivity.
Published testing of seized and purchased samples frequently reports discrepancies between declared and measured peptide content. Counter-ion content and residual solvents add further variation. Independent analysis is the only way to confirm composition.
It is a synthetic cyclic heptapeptide modelled on alpha-melanocyte-stimulating hormone. A lactam bridge links two side chains, forming a ring that stabilises the molecule against proteolysis. It belongs to the broader melanocortin peptide family.